Abstract
Infections after total hip replacements are serious complications. They can be triggered either exogenously (intra- or perioperatively) or endogenously (haematogenously). In our own patient population, the infection rate was 0.82% in 1098 primary prostheses and 1.16% in 330 revisions. Considering just the predominantly exogenous infections, which almost always manifested themselves during the first 2 years, the respective infection rates were 0.4% and 0.35%. We distinguish between three types depending on the interval between operation and the manifestation of the infection:
-
Early infection: manifestation up to the end of the 3rd month
-
Delayed infection (mostly low-grade infection): from the 4th month up to 2 years after operation
-
Late infection: from the 3rd year after operation
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Berbari EF, Haussen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, Osmon DR (1998) Risk factors for prosthetic joint infection: case control study. Clin Infect Dis 27: 1247–1254
Brunazzi M, Mcharo C, Ochsner PE (1996) Hüfttotalprothesenwechsel — was erwartet den Patienten? Schweiz Med Wochenschr 126: 2013–2020
Cheung A, Lachiewicz P, Renner J (1997) The role of aspiration and contrast-enhanced arthrography in evaluating the uncemented hip arthroplasty. AJR 168: 1305–1309
Corstens FHM, Meer JWM van der (1999) Nuclear medicine’s role in infection and inflammation. Lancet 354: 765–770
Deacon JM, Pagliaro AJ, Zelicof SB, Horowitz HW (1998) Prophylactic use of antibiotics for procedures after total joint replacement. J Bone Joint Surg 78 (A): 1755–1770
Elke R, Zimmerh W, Morscher E (1997) Das infizierte Implantat und die septische Lockerung. In: Die Hüfte. Enke, Stuttgart, S 274–283
Engelbrecht E, Siegel A, Kappus M (1995) Totale Hüftendoprothese nach Resektions-arthroplastik. Orthopäde 24: 344–352
Fitzgerald R (1995) Diagnosis and management of the infected hip prostheses. Orthopedics 18: 833–835
Hauser R, Berchtold W, Schreiber A (1996) Incidence of deep sepsis in uncemented total hip arthroplasty using clean air facility as a function of antibiotic prophylaxis. Bull Hosp Jt Dis 54: 175–179
Hunger T, Gösele A, Ochsner PE (1993) Implantierbares Venenkathetersystem zur ambulanten Langzeit-Antibiotikatherapie bei chronischer Osteomyelitis. Hefte Unfallchir 230: 1032–1035
Lehman CR, Ries MD, Paiement GD, Davidson AB (2001) Infection after total joint arthroplasty in patients with human immunodeficiency virus or intraveneous drug use. J Arthroplasty 16: 330–335
Liebermann J, Callaway G, Salvati E, Pellicci P, Brause B (1994) Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop 301: 205–212
Morscher E, Herzog R, Babst R, Zimmerh W (1995) Management of infected hip arthroplasty. Orthop Int 3: 343–351
Morscher E, Babst R, Jenny H (1990) Treatment of infected joint arthroplasty. Int Orthop 14: 161–165, 18: 833-835
Pfister A, Ochsner PE (1993) Erfahrungen mit geschlossenen Spül-Saug-Drainagen und gleichzeitiger Anwendung eines Antiseptikums. Unfallchirurg 96: 332–340
Ochsner PE, Brunazzi M, Picard C (1995) Rettungseingriffe bei chronischem Infekt nach Hüfttotalprothesen. Orthopäde 24: 353–359
Ochsner PE, Hauser R, Lotz M (1987) Diagnostik und Therapie der Skelettinfektionen aus orthopädischer Sicht. Praxis 76: 532–542
Salvati E (1994) Diagnosis and management of the infected hip. Orthopedics 17: 811–814
Schafroth MU, Ochsner PE (1999) Does Staphylococcus aureus infection worsen the prognosis for treatment of infected total hip replacement? Eur J Orthop Surg Traumatol 9: 241–244
Schafroth MU, Zimmerh W, Ochsner PE (1999) Das infizierte künstliche Hüftgelenk: Möglichkeiten, Verlauf und Resultate der Behandlung. Praxis 88: 2101–2105
Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV et al. (1999) Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 340: 493–501
Taylor T, Beggs I (1995) Fine needle aspiration in infected hip replacements. Clin Radiol 50: 149–152
Tigges S, Stiles R, Roberson J (1994) Appearance of septic hip prostheses on plain radiographs. AJR 163: 377–380
Tunney MM, Patrick S, Curran MD, Ramage G, Hanna D, Nixon JR, Gorman SP, Davis RI, Anderson N (1999) Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PGR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 37: 3281–3290
Widmer AF, Colombo VE, Gächter A, Thiel G, Zimmerli W (1990) Salmonella infection in total hip replacement: tests to predict the outcome of antimicrobial therapy. Scand J Infect Dis 22: 611–618
Wilde A (1994) Management of infected knee and hip prosthesis. Rheumatology 6: 172–176
Willenegger H, Roth B (1986) Behandlungstaktik und Spätergebnisse bei Frühinfekt nach Osteosynthese. Unfallchirurgie 12: 241–246
Willenegger H, Roth B, Ochsner PE (1995) The return of local antiseptics in surgery. Injury 26: Suppl 1
Wroblewski B, Siney P (1993) Charnley low-friction arthroplasty of the hip. Long-term results. Clin Orthop 292: 191–201
Younger A, Duncan C, Masri B, McGraw R (1997) The outcome of two-stage arthroplasty using a custommade interval spacer to treat the infected hip. J Arthroplasty 12: 615–623
Zimmerh W (1984) Hämatogener Protheseninfekt beim Menschen und im Tiermodell. Schweiz Med Wochenschr 114: 1756–1757
Zimmerli W, Zak 0, Vosbeck K (1985) Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 17: 303–310
Zimmerli W, Frei R, Widmer AF, Rajacic Z (1994) Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 33: 959–967
Zimmerh W, Widmer A, Blatter M, Frei R, Ochsner PE (1998) Role of rifampicin for treatment of orthopedic implant-related staphylococcal infections. JAMA 279: 1537–1541
Zimmerh W (1999) Prosthetic device infection. In: Root RK et al. (eds) Clinical infectious diseases: a practical approach. Oxford Univ Press, London, pp 801–808
Zimmerli W (2000) Antibiotic prophylaxis. In: Rüedi TP et al. (eds) AO principles of fracture management. Thieme, Stuttgart, pp 699–707
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schafroth, M., Zimmerli, W., Brunazzi, M., Ochsner, P.E. (2003). Infections. In: Ochsner, P.E. (eds) Total Hip Replacement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55679-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-55679-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62868-9
Online ISBN: 978-3-642-55679-1
eBook Packages: Springer Book Archive